Purklenz Liquid
NDC 49436-291
Product Information
Purklenz (chloroxylenol) is a OTC MONOGRAPH DRUG-approved product labeled by Purklenz Formulations Inc.. This product is primarily utilized in pharmaceutical processing or compounding. It is supplied as a liquid for topical administration. This product entry covers the primary NDC 49436-291 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Clinical Specifications
Labeler & Regulatory Data
Marketing Timeline
Code Structure Chart
Product Details
What is NDC 49436-291?
What are the uses of this product?
What are Active Ingredients of this product?
- CHLOROXYLENOL 2.949 g/100mL - topical antiseptic; RN given refers to parent cpd; structure
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- CHLOROXYLENOL (UNII: 0F32U78V2Q)
- CHLOROXYLENOL (UNII: 0F32U78V2Q) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- WATER (UNII: 059QF0KO0R)
- SODIUM LAURETH SULFATE (UNII: BPV390UAP0)
- PROPYLENE GLYCOL (UNII: 6DC9Q167V3)
- COCAMIDOPROPYL BETAINE (UNII: 5OCF3O11KX)
- PPG-2 HYDROXYETHYL COCAMIDE (UNII: 34N07GUJ3X)
- HYPROMELLOSES (UNII: 3NXW29V3WO)
- CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP)
- EDETATE SODIUM (UNII: MP1J8420LU)
- LANOLIN OIL (UNII: OVV5IIJ58F)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 1537468 - PURKlenz 3 % Topical Solution
- RxCUI: 1537468 - chloroxylenol 30 MG/ML Topical Solution [Purklenz]
- RxCUI: 1537468 - Purklenz 3 % Topical Solution
- RxCUI: 1537468 - Purklenz 30 MG/ML Topical Solution
- RxCUI: 247396 - chloroxylenol 3 % Topical Solution
* Please review the full disclaimer at the bottom of this page.